Monday morning, MRI in hand
A familiar midlife presentation in MSK clinics: medial joint-line pain after a twist that was not dramatic, intermittent catching, stairs that feel awkward, and an MRI report that names a degenerative medial meniscal tear. There is no true locked knee. There is no recent high-energy trauma with a bucket-handle tear. The room question arrives quickly: “So when do we book the arthroscopy?”
That question is understandable. For years, trimming a torn meniscus felt like the obvious fix. The better first question for many degenerative presentations is different: what does high-quality evidence say about arthroscopic partial meniscectomy (APM) compared with exercise — or even sham surgery — and when does shared decision-making still leave a clear surgical role?
This article is about that decision. It is not a repeat of ManualCPD’s knee osteoarthritis core-pathway piece. Osteoarthritis care asks what first-line non-surgical management should look like. Degenerative meniscal tear care asks whether routine keyhole resection outperforms carefully delivered exercise and education for people whose MRI shows a tear that often travels with early joint degeneration.
The tear on the scan is common — and often not the whole story
Meniscal damage on MRI is common in middle age and later life. Englund and colleagues’ population MRI work showed that incidental meniscal findings rise with age, and that a large share of people with a tear report no recent knee pain, aching, or stiffness. A report that says “meniscal tear” is therefore not automatically a ticket to theatre. It is one piece of information in a knee that may already be on an osteoarthritis spectrum.
That framing matters clinically. Symptoms attributed to a degenerative meniscus may partly reflect broader joint irritability, load intolerance, and early OA biology rather than a single flap that must be cut away. Treating the report as destiny is how people arrive expecting surgery before a loading plan has been tried.
What FIDELITY showed — including at ten years
The FIDELITY trial (Finnish Degenerative Meniscal Lesion Study) remains the cleanest test of whether APM itself helps people with a degenerative medial meniscal tear and no established radiographic osteoarthritis. Sihvonen and colleagues randomised 146 adults aged 35–65 to APM or sham surgery after diagnostic arthroscopy confirmed eligibility (ClinicalTrials.gov NCT00549172). Primary outcomes at twelve months — Lysholm score, Western Ontario Meniscal Evaluation Tool (WOMET), and knee pain after exercise — did not differ meaningfully between groups. Both groups improved; APM was not superior to sham (N Engl J Med 2013;369:2515–2524).
That finding already challenged the habit of offering APM as default care for degenerative tears without OA. The ten-year FIDELITY letter strengthens the caution. With about 91% follow-up, adjusted mean differences favoured sham on WOMET (−9.4 points; 98.33% CI −17.0 to −1.7). Lysholm and pain-after-exercise differences trended in the same direction without clearly excluding no difference on those measures. Radiographic osteoarthritis progression was common in both groups (81% after APM vs 70% after sham; adjusted risk difference 12 percentage points, 95% CI −1 to 26). Subsequent knee replacement or high tibial osteotomy was more frequent after APM than sham in the reported counts (N Engl J Med 2026;394:1757–1759).
FIDELITY does not say every meniscus operation is useless. It says that in the degenerative medial tear population without established radiographic OA — the group in whom benefit from resection might have been easiest to show — APM did not outperform sham, and longer-term signals do not reassure. That is the opposite of a trivial result.
A secondary FIDELITY analysis also matters for clinic language: mechanical symptoms such as catching did not identify a subgroup that clearly benefited from APM (Ann Intern Med 2016;164:449–455). “They have catching” is not, by itself, proof that resection will outperform non-operative care in degenerative disease.
Exercise pathways: METEOR and OMEX
Most people do not face a choice between APM and sham. They face a choice between surgery and structured rehabilitation. Two landmark trials speak to that comparison.
METEOR (Katz et al., N Engl J Med 2013) randomised 351 people aged 45 or older with a symptomatic meniscal tear and mild-to-moderate osteoarthritis to APM plus postoperative physiotherapy or a standardised physiotherapy programme alone, with crossover allowed. At six months, intention-to-treat WOMAC physical-function improvement was 20.9 points with surgery versus 18.5 with physiotherapy (mean difference 2.4; 95% CI −1.8 to 6.5). About 30% of the physiotherapy group crossed over to surgery within six months. Results at twelve months were similar. The honest clinic translation is not “physiotherapy always wins.” It is that starting with physiotherapy was a reasonable strategy for many, with no clear average superiority of immediate APM on the primary function outcome — while acknowledging that a substantial minority later chose surgery.
OMEX (Kise et al., BMJ 2016) compared twelve weeks of supervised exercise therapy with APM alone in middle-aged patients with degenerative meniscal tear and no definitive radiographic OA. At two years, the between-group difference in KOOS4 was 0.9 points (95% CI −4.3 to 6.1) — excluding a clinically important advantage for either arm. Exercise improved thigh muscle strength at three months. Nineteen percent of the exercise arm crossed over to surgery over two years, without clear additional benefit from that crossover. Longer OMEX follow-up has reported no essential between-group difference in radiographic OA progression and comparable patient-reported improvement patterns.
Together, METEOR and OMEX support exercise-first care for many degenerative presentations, while reminding clinicians that some people will still request or need surgical reassessment if symptoms remain unacceptable after an adequate non-operative trial.
What UK and European guidance already asks you to do
You do not have to invent a pathway from the trials alone.
The British Association for Surgery of the Knee (BASK) 2019 national treatment guideline and consensus statement (Abram, Beard, Price; Bone Joint J 2019;101-B:652–659) stratifies presentations. Urgent arthroscopic meniscal surgery is recommended for a locked knee. After acute injury with a reparable target lesion, meniscal repair should be considered to preserve tissue. For most other patients with a target lesion and corresponding symptoms, a minimum of three months of non-surgical therapy is recommended before considering non-urgent APM. Patients without a clear target lesion or with only possibly meniscal features need further optimised non-surgical care. Advanced osteoarthritis is generally a “no arthroscopic meniscal surgery” pathway, with rare special cases needing documented second opinion. Shared decision-making remains explicit: guidance supports judgement; it does not replace it.
NHS England Evidence-Based Interventions (EBI) guidance on arthroscopic surgery for meniscal tears (reviewed September 2024) aligns with BASK: the vast majority should start with education, physiotherapy, and weight-loss support where relevant; locked knee and potentially repairable acute tears are the main first-line surgical exceptions; persistent symptoms after about three months of non-operative care may justify MRI and consideration of surgery for an unstable tear.
The 2016 ESSKA degenerative meniscus consensus likewise states that APM should not be proposed as first-line treatment for degenerative meniscus lesions; consider it only after standardised assessment and unsatisfactory response to non-operative care.
For people whose dominant problem is osteoarthritis rather than a discrete meniscal target, NICE NG226 is also relevant: do not offer arthroscopic lavage or debridement for osteoarthritis. That OA “do not do” is adjacent to — not identical with — BASK’s more granular meniscal pathway, but it reinforces that keyhole surgery is not a default fix for degenerative knee pain.
What exercise-first actually means in clinic
“Try physio” is not a pathway. A usable degenerative-meniscus plan usually includes:
Education that matches the evidence. Explain that degenerative tears are common on MRI, that symptoms often improve without resecting tissue, and that APM has not outperformed sham or exercise for many people in this category. Avoid promising that “tidying the tear” will restore a young knee.
Progressive strengthening and neuromuscular work. Target quadriceps, hip, and calf capacity; include functional tasks the person actually needs (stairs, squat pattern, work demands). Supervised sessions help early when confidence or technique is limiting.
Load management without fear. Reduce provocative spikes; keep a floor of tolerable activity; progress rather than rest indefinitely.
Time-bound review. BASK’s three-month non-surgical window is a useful shared reference — not a hard stop for everyone, and not a reason to abandon people with a locked knee or clear traumatic surgical indication.
Honest discussion of crossover and uncertainty. Some people will not improve enough. Reassess mechanical block, true locking, reparable traumatic patterns, and whether symptoms remain meniscal-predominant after adequate rehab. Shared decision-making includes the option of surgical referral after a fair non-operative trial — without pretending the average trial effect of APM is large in degenerative disease.
Manual therapy, if you use it, can help settle irritability enough to load. It is not a substitute for a capacity plan. Imaging should support decisions, not drive them: MRI is often more useful after an adequate non-operative trial or when traumatic/repairable pathology is suspected, rather than as an automatic first step for every midlife joint-line ache.
Who still needs a surgical conversation sooner
Fail-safe exceptions matter. Do not force an exercise-first script onto presentations the guidance treats differently:
- True locked knee with suspected displaced tear — urgent assessment; often arthroscopic management.
- Acute injury with a potentially repairable meniscal tear — consider repair to preserve meniscus, especially in younger or higher-demand knees.
- Clear traumatic patterns (for example unstable bucket-handle tears) — these are not the FIDELITY degenerative population.
- Advanced OA with arthritic-predominant symptoms — APM is generally inappropriate; discuss OA pathway care and, where quality of life remains poor despite core non-surgical care, arthroplasty pathways rather than “just trim the meniscus.”
Preserve uncertainty where trials leave it. Populations differ (no OA vs mild–moderate OA). Crossover complicates interpretation. “Mechanical symptoms” are inconsistently defined. Individual values — sport demands, work deadlines, risk tolerance — belong in the conversation. The evidence reduces confidence in routine APM for degenerative tears; it does not erase every surgical indication.
Monday-morning implications
For the next person with a degenerative meniscal tear on MRI, joint-line pain, no locked knee, and no clear traumatic repair indication:
- Do not treat the MRI line as an automatic theatre booking.
- Explain that APM did not beat sham in FIDELITY, and did not clearly beat structured exercise in METEOR/OMEX for average outcomes in their populations.
- Write a supervised, progressive strengthening and functional loading plan with a review point (often around three months, aligned with BASK/EBI).
- Use catching/clicking language carefully; mechanical symptoms alone do not prove APM will help in degenerative disease.
- Escalate sooner for locking, acute reparable tears, or failure of an adequate non-operative trial with ongoing meniscal-predominant symptoms.
- Keep OA core care in view when degeneration is broader than a single meniscal line — exercise, education, weight management where relevant — and do not sell arthroscopic washout as OA treatment under NG226.
Degenerative meniscal tears are a shared-decision problem, not a reflex resection problem. Exercise and education first for most; surgery reserved for specific indications and for people who remain unacceptably limited after a real rehabilitation trial. That is not softer MSK practice. It is the version the sham-controlled trials and national knee guidance already describe.